Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Critical roles of αII spectrin in brain development and epileptic encephalopathy
Yu Wang, … , Paul M. Jenkins, Jack M. Parent
Yu Wang, … , Paul M. Jenkins, Jack M. Parent
Published January 16, 2018
Citation Information: J Clin Invest. 2018;128(2):760-773. https://doi.org/10.1172/JCI95743.
View: Text | PDF
Research Article Development Neuroscience

Critical roles of αII spectrin in brain development and epileptic encephalopathy

  • Text
  • PDF
Abstract

The nonerythrocytic α-spectrin-1 (SPTAN1) gene encodes the cytoskeletal protein αII spectrin. Mutations in SPTAN1 cause early infantile epileptic encephalopathy type 5 (EIEE5); however, the role of αII spectrin in neurodevelopment and EIEE5 pathogenesis is unknown. Prior work suggests that αII spectrin is absent in the axon initial segment (AIS) and contributes to a diffusion barrier in the distal axon. Here, we have shown that αII spectrin is expressed ubiquitously in rodent and human somatodendritic and axonal domains. CRISPR-mediated deletion of Sptan1 in embryonic rat forebrain by in utero electroporation caused altered dendritic and axonal development, loss of the AIS, and decreased inhibitory innervation. Overexpression of human EIEE5 mutant SPTAN1 in embryonic rat forebrain and mouse hippocampal neurons led to similar developmental defects that were also observed in EIEE5 patient-derived neurons. Additionally, patient-derived neurons displayed aggregation of spectrin complexes. Taken together, these findings implicate αII spectrin in critical aspects of dendritic and axonal development and synaptogenesis, and support a dominant-negative mechanism of SPTAN1 mutations in EIEE5.

Authors

Yu Wang, Tuo Ji, Andrew D. Nelson, Katarzyna Glanowska, Geoffrey G. Murphy, Paul M. Jenkins, Jack M. Parent

×

Figure 2

Sptan1 CRISPR in utero electroporation.

Options: View larger image (or click on image) Download as PowerPoint

Sptan1 CRISPR in utero electroporation.
(A) Schematic representation of...
(A) Schematic representation of IUE and the CRISPR validation methods. FACS-sorted GFP-labeled cells are processed for next-generation sequencing to identify specific mutations. Brain sections are immunostained to visualize the in vivo qualitative change in αII spectrin immunostaining. Immunostaining on dissociated cortical neurons is performed to quantify the efficiency of Sptan1 CRISPR knockout. (B) Representative confocal image from a P1 brain section after prior transfection with Sptan1 CRISPR A at E13–14. Sptan1 CRISPR–transfected cells are marked by GFP (green) in the cerebral cortex (CTX, between the dashed lines). These cells also project axons to the contralateral hemisphere through white matter (WM). Red, αII spectrin; blue, bisbenzimide (BB) nuclear stain. (C) The area outlined by the dotted square (same image as in B) with a high density of GFP labeling has a marked reduction in αII spectrin immunoreactivity. Another area with a cluster of GFP+ cells in the WM (arrow) also demonstrates a clear lack of αII spectrin staining compared with the surrounding nontransfected (GFP–) area. Note that these regions do not have homogeneous loss of αII spectrin owing to the mosaic mutation introduced by CRISPR IUE. (D) Quantification of fluorescence intensity across the transfected regions (yellow box) shows that the intensities of αII spectrin and GFP signals are inversely correlated. (E) Representative confocal image of αII spectrin (magenta) and RFP expression (white) in rat cortical neurons dissociated from brains 4 days after IUE with Sptan1 CRISPR gRNA and RFP (to label the cells) at E14–15, then cultured for 10 days. Three RFP+ cells lack αII spectrin immunoreactivity, whereas other RFP– cells are αII spectrin positive. Scale bars: 100 μm in B (for B–D), 50 μm in E.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts